PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 185 filers reported holding PTC THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 1.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,397,943 | -44.2% | 107,004 | +1.3% | 0.00% | -40.0% |
Q2 2023 | $4,298,086 | +85741.5% | 105,682 | +2.2% | 0.01% | -16.7% |
Q1 2023 | $5,007 | +29.1% | 103,370 | +1.7% | 0.01% | +20.0% |
Q4 2022 | $3,879 | -99.9% | 101,634 | +3.1% | 0.01% | -28.6% |
Q3 2022 | $4,951,000 | +37.9% | 98,619 | +10.0% | 0.01% | +40.0% |
Q2 2022 | $3,590,000 | +29.9% | 89,619 | +21.0% | 0.01% | +25.0% |
Q1 2022 | $2,764,000 | -6.4% | 74,083 | -0.1% | 0.00% | 0.0% |
Q4 2021 | $2,954,000 | +5.8% | 74,155 | -1.2% | 0.00% | 0.0% |
Q3 2021 | $2,792,000 | -12.9% | 75,041 | -1.1% | 0.00% | 0.0% |
Q2 2021 | $3,206,000 | -6.0% | 75,850 | +5.4% | 0.00% | -20.0% |
Q1 2021 | $3,409,000 | -30.7% | 71,986 | -10.7% | 0.01% | -28.6% |
Q4 2020 | $4,918,000 | +34.3% | 80,576 | +2.9% | 0.01% | +16.7% |
Q3 2020 | $3,661,000 | -27.4% | 78,318 | -21.2% | 0.01% | -25.0% |
Q2 2020 | $5,042,000 | +26.9% | 99,370 | +11.6% | 0.01% | 0.0% |
Q1 2020 | $3,973,000 | -6.0% | 89,054 | +1.2% | 0.01% | +14.3% |
Q4 2019 | $4,225,000 | +54.6% | 87,963 | +8.8% | 0.01% | +40.0% |
Q3 2019 | $2,733,000 | -23.9% | 80,822 | +1.3% | 0.01% | -28.6% |
Q2 2019 | $3,589,000 | +40.2% | 79,765 | +17.3% | 0.01% | +40.0% |
Q1 2019 | $2,560,000 | +23.6% | 68,003 | +12.6% | 0.01% | 0.0% |
Q4 2018 | $2,072,000 | +7.7% | 60,379 | +47.5% | 0.01% | +25.0% |
Q3 2018 | $1,924,000 | +30.5% | 40,935 | -6.3% | 0.00% | +33.3% |
Q2 2018 | $1,474,000 | +42.6% | 43,696 | +14.4% | 0.00% | +50.0% |
Q1 2018 | $1,034,000 | +58.1% | 38,193 | -2.6% | 0.00% | +100.0% |
Q4 2017 | $654,000 | -22.3% | 39,196 | -6.9% | 0.00% | -50.0% |
Q3 2017 | $842,000 | +18.4% | 42,103 | +8.6% | 0.00% | 0.0% |
Q2 2017 | $711,000 | +70.9% | 38,768 | -8.3% | 0.00% | +100.0% |
Q1 2017 | $416,000 | -7.3% | 42,293 | +2.9% | 0.00% | 0.0% |
Q4 2016 | $449,000 | -23.9% | 41,120 | -2.3% | 0.00% | -50.0% |
Q3 2016 | $590,000 | +70.5% | 42,092 | -14.7% | 0.00% | +100.0% |
Q2 2016 | $346,000 | +58.0% | 49,335 | +45.2% | 0.00% | 0.0% |
Q1 2016 | $219,000 | -79.7% | 33,987 | +2.2% | 0.00% | -66.7% |
Q4 2015 | $1,077,000 | +31.2% | 33,247 | +8.1% | 0.00% | 0.0% |
Q3 2015 | $821,000 | -44.7% | 30,762 | -0.3% | 0.00% | -40.0% |
Q2 2015 | $1,485,000 | -5.2% | 30,858 | +19.8% | 0.01% | 0.0% |
Q1 2015 | $1,567,000 | +42.5% | 25,748 | +21.2% | 0.01% | +66.7% |
Q4 2014 | $1,100,000 | +29.9% | 21,243 | +10.4% | 0.00% | 0.0% |
Q3 2014 | $847,000 | +69.4% | 19,243 | +0.7% | 0.00% | +200.0% |
Q2 2014 | $500,000 | – | 19,113 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
Chubb Ltd | 8,180 | $393,000 | 1.68% |